DarioHealth (NASDAQ:DRIO) is scheduled to be issuing its quarterly earnings data before the market opens on Monday, October 28th. Parties that are interested in participating in the company’s conference call can do so using this link.
DarioHealth (NASDAQ:DRIO) last posted its earnings results on Tuesday, August 13th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. The company had revenue of $1.65 million during the quarter. DarioHealth had a negative return on equity of 270.42% and a negative net margin of 265.04%.
DarioHealth stock opened at $0.25 on Monday. The business has a fifty day moving average of $0.34 and a two-hundred day moving average of $0.52. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 1.89. DarioHealth has a twelve month low of $0.23 and a twelve month high of $1.32.
DarioHealth Company Profile
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device.
Recommended Story: Why are analyst ratings important in trading stocks?
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.